Riché F, Panis Y, Laisné M J, Briard C, Cholley B, Bernard-Poenaru O, Graulet A M, Guéris J, Valleur P
Department of Anesthesiology, Lariboisière Hospital, Paris, France.
Surgery. 1996 Nov;120(5):801-7. doi: 10.1016/s0039-6060(96)80087-0.
In several studies including patients with septic shock of various origins, high serum cytokine levels have been reported to correlate with poor outcome. The aim of this prospective study was to assess the prognostic value of cytokine serum levels in a group of patients with perioperative septic shock of digestive origin.
From January 1992 to December 1994, 59 patients were evaluated (mean age, 68 +/- 15 years). From the first day of septic shock to day 7, blood was drawn every day to measure the conventional biologic parameters (white blood cell count, platelet count, hematocrit, blood urea nitrogen level, serum electrolytes level, pH, blood gases, serum lactate level, coagulation parameters, liver function tests) and tumor necrosis factor (TNF), interleukin-1, and interleukin-6.
No difference was observed between the 26 survivors and the 33 nonsurvivors with regard to age, gender, and cause of sepsis. On admission, mean platelet count was significantly higher in the survivors than in the nonsurvivors (260 +/- 142 versus 177 +/- 122 10(9)/L; p = 0.01). Mean blood urea nitrogen level was significantly lower in the survivors than in the nonsurvivors (9.6 +/- 9 versus 12 +/- 7 mmol/L; p = 0.04). No difference was observed between survivors and nonsurvivors for the other conventional biologic parameters and for serum interleukin-1 and interleukin-6 levels. Mean serum TNF level tended to be higher in survivors than in nonsurvivors (565 +/- 1325 versus 94 +/- 69 pg/ml; not significant). In the group survivor 9 (35%) of 26 patients had a serum TNF level greater than 200 pg/ml versus 2 (6%) of 33 patients in the nonsurvivor group (p < 0.02). Survival was noted in 6 (100%) of 6 patients who had both a serum TNF level greater than 200 pg/ml and a platelet count greater than 100.10(9)/L versus 1 (11%) of 9 in patients with neither of these criteria (p < 0.01).
In our patients with abdominal septic shock, high serum TNF levels were associated with increased survival. The high serum level of TNF may reflect the efficacy of peritoneal inflammatory response against abdominal sepsis. Although this possibility must be further explored, a score combining the serum TNF level and platelet count could be helpful for the prognostic assessment of patients with abdominal septic shock.
在多项涉及各种病因所致脓毒性休克患者的研究中,均报告血清细胞因子水平升高与预后不良相关。本前瞻性研究的目的是评估一组消化源性围手术期脓毒性休克患者血清细胞因子水平的预后价值。
1992年1月至1994年12月,对59例患者进行了评估(平均年龄68±15岁)。从脓毒性休克第1天至第7天,每天采集血液以检测常规生物学参数(白细胞计数、血小板计数、血细胞比容、血尿素氮水平、血清电解质水平、pH值、血气、血清乳酸水平、凝血参数、肝功能检查)以及肿瘤坏死因子(TNF)、白细胞介素-1和白细胞介素-6。
26例存活者与33例非存活者在年龄、性别和脓毒症病因方面未观察到差异。入院时,存活者的平均血小板计数显著高于非存活者(260±142对177±122×10⁹/L;p = 0.01)。存活者的平均血尿素氮水平显著低于非存活者(9.6±9对12±7 mmol/L;p = 0.04)。在其他常规生物学参数以及血清白细胞介素-1和白细胞介素-6水平方面,存活者与非存活者之间未观察到差异。存活者的平均血清TNF水平倾向于高于非存活者(565±1325对94±69 pg/ml;无显著性差异)。26例存活患者中有9例(35%)血清TNF水平大于200 pg/ml,而非存活组33例患者中有2例(6%)(p < 0.02)。血清TNF水平大于200 pg/ml且血小板计数大于100×10⁹/L的6例患者中有6例(100%)存活,而不具备这两个标准的9例患者中仅有1例(11%)存活(p < 0.01)。
在我们的腹部脓毒性休克患者中,高血清TNF水平与存活率增加相关。高血清TNF水平可能反映了腹膜对腹部脓毒症炎症反应的有效性。尽管这种可能性必须进一步探究,但结合血清TNF水平和血小板计数的评分可能有助于腹部脓毒性休克患者的预后评估。